~~<i id='1F6988C3E3'><strike id='1F6988C3E3'><tt id='1F6988C3E3'><pre id='1F6988C3E3'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

Wikipedia

fashion

author：focus 2025-10-01 23:31:23 - browse：5

The Roche booth at ESMO in Madrid. — Roche's booth at the 2023 ESMO conference. Andrew Joseph/STAT

MADRID — A Roche drug lowered the risk of recurrence or death by 76% versus chemotherapy for patients with a type of early non-small cell lung cancer, according to data from a Phase 3 trial presented Saturday.

The findings, which Roche is planning to submit to regulators, could give patients with early-stage ALK-positive cancers another option. The standard treatment after surgery for these patients is chemotherapy.

The results from the Alina trial were presented here at the annual meeting of the European Society for Medical Oncology.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Peter Hotez and the public health issue of online harassment
Next article： Oprah kicked off a national conversation on obesity. Let's have it

focus

Wikipedia

knowledge

hotspot

explore

Wikipedia

Inanewhealthalert,theCDCsaidcliniciansshouldprioritizeavailableBeyfortusdosesforbabiesathighestriskf

WSS

Food as medicine: Medically tailored meals may get standardized

Abortion pill case raises question: who can sue the FDA?

Food as medicine: Medically tailored meals may get standardized

Readout Newsletter: Cardior, Regeneron, Nuvation, Dyne and more

Cassava reveals details — and problems — with Alzheimer's study

Abortion pill Supreme Court ruling could impact entire drug industry

Wikipedia

fashion

focus

Dobbs anniversary: the lost opportunity of abortion as health care

Diversifying clinical trials isn't enough to close racial gaps: study

Anesthesiologist group: stop taking Ozempic before surgery

Readout Newsletter: What happened with Sarepta's Duchenne data

Supreme Court strikes down use of affirmative action

Hospitals warn Medicare's drug payment fix is ‘unlawful’

Medical leaders decry Supreme Court decision on affirmative action

Readout LOUD podcast: mifepristone case, GLP

At least 13 dead in Texas as scorching temps continue

Readout Newsletter: New research from Sanofi, Regeneron, etc.

Wikipedia

Readout Newsletter: What happened with Sarepta's Duchenne data

Eli Lilly to pay $200M for Beam’s stake in gene

WHO may add ‘noma' to its list of neglected tropical diseases

Chimpanzees, like humans and whales, get menopause: Study

Scientists boost immune system in aging mice by making it youthful

Patient advocates debate FDA's accelerated approval process

knowledge

hotspot

explore

Wikipedia